1
Participants
Start Date
May 31, 2015
Primary Completion Date
January 8, 2024
Study Completion Date
January 8, 2024
Sentinel lymph node mapping
Thirty (30) patients will be enrolled under informed consent based upon their medical diagnosis, planned surgical procedures, and suitability for the procedure. During the study, patients will receive injections of ICG and will be imaged using a commercial NIR imaging system (Pinpoint, Novadaq, Waterloo ON). After the study, patients will continue with their planned management.
Indocyanine Green (ICG)
near-infrared fluorescence (NIR) imaging (Pinpoint, Novadaq, Waterloo)
University Health Network, Toronto
University Health Network, Toronto
OTHER